Normal 0 14 false false false IT X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Tabella normale"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;}

Il giorno 12 Novembre 2019 alle ore 12.00 nell'Aula Magna della Clinica Pediatrica, in Viale Regina Elena 324 il Prof. Mark Mercola del Stanford Cardiovascular Institute and Dep. of Medicine, Stanford University, terrà il seminario dal titolo :

"Generating Safe and Effective Drugs for Heart Disease and Cancer using Patient iPSCs”.

In allegato la locandina